Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hasenclever

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 10, 2020
Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV<sub>max</sub> MethodJan Rekowski, Andreas Hüttmann, Christine Schmitz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 8, 2014
qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphomaDirk Hasenclever, Lars Kurch, Christine Mauz-Körholz, et al.
International Journal of Cancer|June 23, 2015
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancerGunnar Wichmann, Maciej Rosolowski, Knut Krohn, et al.
Haematologica|November 2, 2013
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphomaSietse M Aukema, Markus Kreuz, Christian W Kohler, et al.
Blood Advances|June 3, 2026
​EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphomaAnanth G Shankar, Judith Landman-Parker, Maurizio Mascarin, et al.
Scientific Reports|July 6, 2026
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphomaJonas Steglich, Andishe Attarbaschi, Auke Beishuizen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma PatientsThomas W Georgi, Dietrich Stoevesandt, Lars Kurch, et al.
Pediatric Radiology|January 31, 2024
Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial stagingDietrich Stoevesandt, Christiane Ludwig, Christine Mauz-Körholz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5Markus Sieber, Hans Tesch, Beate Pfistner, et al.
ESC Heart Failure|June 23, 2018
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)Anne-Catherine Pouleur, Stefan Anker, Dulce Brito, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 10, 2020
Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV<sub>max</sub> MethodJan Rekowski, Andreas Hüttmann, Christine Schmitz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 8, 2014
qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphomaDirk Hasenclever, Lars Kurch, Christine Mauz-Körholz, et al.
International Journal of Cancer|June 23, 2015
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancerGunnar Wichmann, Maciej Rosolowski, Knut Krohn, et al.
Haematologica|November 2, 2013
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphomaSietse M Aukema, Markus Kreuz, Christian W Kohler, et al.
Blood Advances|June 3, 2026
​EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphomaAnanth G Shankar, Judith Landman-Parker, Maurizio Mascarin, et al.
Scientific Reports|July 6, 2026
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphomaJonas Steglich, Andishe Attarbaschi, Auke Beishuizen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma PatientsThomas W Georgi, Dietrich Stoevesandt, Lars Kurch, et al.
Pediatric Radiology|January 31, 2024
Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial stagingDietrich Stoevesandt, Christiane Ludwig, Christine Mauz-Körholz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5Markus Sieber, Hans Tesch, Beate Pfistner, et al.
ESC Heart Failure|June 23, 2018
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)Anne-Catherine Pouleur, Stefan Anker, Dulce Brito, et al.
Pageof 10